Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Brainsway Ltd ADR (NQ: BWAY )

9.790 +0.110 (+1.14%)
Streaming Delayed Price Updated: 9:44 AM EST, Nov 29, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Brainsway Ltd ADR

< Previous 1 2 3 Next >
Low-Priced, High-Potential: 7 Cheap Stocks Under $10 to Try Your Luck With
Although lesser-known ideas present high risks, these cheap stocks under $10 could be intriguing for the calculating speculator. 
Via InvestorPlace
7 High-Growth Stocks to Snag for Spectacular Returns in 2024
Discover 2024's top seven high-growth stocks, blending innovative tech, strategic scalability, and market dominance for high returns. 
Via InvestorPlace
Biotech Stocks Are on Fire: Here Are the Top 3 Picks for January
These biotech stocks offer exciting and disruptive solutions with the potential to expand to market caps worth trillions. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
7 Under-the-Radar Stocks Gearing Up for a 2025 Breakthrough
Are you looking to invest in under-the-radar stocks? Here are seven under-the-radar stocks gearing up for a 2025 breakthrough. 
Via InvestorPlace
5 Analysts Have This to Say About BrainsWay
Via Benzinga
Preview: BrainsWay's Earnings
Via Benzinga
Earnings Outlook For BrainsWay
Via Benzinga
Earnings Scheduled For November 12, 2024
Via Benzinga
What's Going On With BrainsWay Shares Monday?
BrainsWay stock is trading higher on Monday after the company announced a $20 million investment from Valor Equity Partners. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
BWAY Stock Earnings: BrainsWay Beats Revenue for Q2 2024
BWAY stock results show that BrainsWay beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Small-Cap Standouts: 3 Stocks Destined to Rule Their Industries
Undervalued small-cap stocks are en masse. Consider these three best-in-class small-class gems before other investors latch onto them! 
Via InvestorPlace
Trade Desk To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
BWAY Stock Earnings: BrainsWay Beats Revenue for Q1 2024
BWAY stock results show that BrainsWay beat on revenue for the first quarter of 2024. 
Via InvestorPlace
BWAY Stock Earnings: BrainsWay Beats Revenue for Q4 2023
BWAY stock results show that BrainsWay beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
BrainsWay Earnings Preview
Via Benzinga
Earnings Scheduled For March 6, 2024
Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue of $708.85 million. 
Via Benzinga
The Latest Analyst Ratings for BrainsWay
Via Benzinga
BrainsWay: Q1 Earnings Insights
Via Benzinga
Earnings Outlook For BrainsWay
Via Benzinga
A Preview Of Brainsway's Earnings
Via Benzinga
Market Mavericks: 3 Stocks That Could Turn $10K into $100K by 2027
Are you looking for stock multibaggers with high potential? Here are three stocks that could turn $10k into $100k by 2027. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to start off the week with a breakdown of the biggest pre-market stock movers that investors need to know about for Monday! 
Via InvestorPlace
3 Stocks to Buy BEFORE They Become Wall Street Darlings
These are the top stocks to buy before smart money pours into these high-growth businesses with massive addressable markets. 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
What 4 Analyst Ratings Have To Say About BrainsWay
Via Benzinga
Earnings Scheduled For March 15, 2023
Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Neuronetics Settles Unfair Competition Related Litigation Against BrainsWay
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.